Published by mark itwired
Posted on August 6, 2021
7 min readLast updated: February 18, 2026
Add as preferred source on Google
Human milk oligosaccharides (HMO) helps in maintaining infant’s gut microbiota as well as promotes the growth of healthy bacteria and reduce pathogens, preventing infections and others bacterial risks. In recent past, sales of infant nutrition products have increased to a significant extent owing to the continuously rising infant population across the globe. According to WHO, the total world population is estimated to increase by approximately one billion in the next 10 years and will reach 9.5 billion by 2050. Incidentally, demand has been relatively higher to the supply of infant nutrition products. Meanwhile, sales of infant formula are also surging in some of the Asian countries such as China and India, promoting the consumption of HMO alike. Future Market Insights’ latest report reveals that the global human milk oligosaccharides market is set to surpass a valuation of US$ 76 Mn, registering a CAGR of 14.6% between 2017 and 2027. This growth will be primarily orchestrated by the increasing application of HMO in infant nutrition products.
In 2017 and beyond, the human milk oligosaccharides market in Europe is anticipated to witness significant revenue growth. Towards the end of 2027, Europe is anticipated to account for over 49% value share of the global market. Manufacturers in Europe are filing claims for regulatory approvals and product safety certifications in order to use HMO for preparing infant formulas. In North America, the HMO market is currently valued at over US$ 6 Mn and holds the second spot in terms of market size after Europe.
For Information On The Research Approach Used In The Report, Ask Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-4252
FMI’s report, titled “Human Milk Oligosaccharides Market Global Industry Analysis and Opportunity Assessment, 2017 – 2027” also cites that demand for HMO is gaining traction due to a positive perception of its prebiotic properties that help maintain a healthy immune system in infants. In addition, manufacturers are focusing on increasing their production capacities in order to enhance production of HMOs such as 2’-FL (2-fucosyllactose) that can be potentially used as an ingredient in functional food and beverages. zuChem Inc., Glycosyn LLC, Elicityl SA, Jennewein Biotechnologie GmbH, Glycom A/S, Dextra Laboratories Limited, Carbosynth Limited, Inbiose NV, ProZyme, Inc. are the leading companies operating in the global human milk oligosaccharides market.
Key Excerpts of the Report Include:
For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-4252
Expert analysis, actionable insights, and strategic recommendations – the food & beverage team at Future Market Insights helps clients from across the globe with their unique business intelligence needs. With a repertoire of over 1,000 reports and 1 million+ data points, the team has analysed the food & beverage industry lucidly in 50+ countries for over a decade. The team provides end-to-end research and consulting services; reach out to explore how we can help.
Explore FMI’s Extensive Coverage on the Food & Beverage Domain
Food Certification Market – 2021 Analysis and Review: Food certification Market by Application – Meat, Poultry, Seafood, Dairy, Infant Food, Beverages, and Bakery & Confectionary for 2021 – 2031
Animal Feed Additives Market – 2021 Analysis and Review: Animal Feed Additives Market by Source Type – Plant, Animal, and Micro-Organisms for 2021-2031
Infant Formula Market – 2021 Analysis and Review: Infant Formula by Product –Starting Milk Formula, Follow-on Milk Formula, Toddlers Milk Formula, and Special Milk Formula for 2021 – 2031
Human milk oligosaccharides (HMO) helps in maintaining infant’s gut microbiota as well as promotes the growth of healthy bacteria and reduce pathogens, preventing infections and others bacterial risks. In recent past, sales of infant nutrition products have increased to a significant extent owing to the continuously rising infant population across the globe. According to WHO, the total world population is estimated to increase by approximately one billion in the next 10 years and will reach 9.5 billion by 2050. Incidentally, demand has been relatively higher to the supply of infant nutrition products. Meanwhile, sales of infant formula are also surging in some of the Asian countries such as China and India, promoting the consumption of HMO alike. Future Market Insights’ latest report reveals that the global human milk oligosaccharides market is set to surpass a valuation of US$ 76 Mn, registering a CAGR of 14.6% between 2017 and 2027. This growth will be primarily orchestrated by the increasing application of HMO in infant nutrition products.
In 2017 and beyond, the human milk oligosaccharides market in Europe is anticipated to witness significant revenue growth. Towards the end of 2027, Europe is anticipated to account for over 49% value share of the global market. Manufacturers in Europe are filing claims for regulatory approvals and product safety certifications in order to use HMO for preparing infant formulas. In North America, the HMO market is currently valued at over US$ 6 Mn and holds the second spot in terms of market size after Europe.
For Information On The Research Approach Used In The Report, Ask Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-4252
FMI’s report, titled “Human Milk Oligosaccharides Market Global Industry Analysis and Opportunity Assessment, 2017 – 2027” also cites that demand for HMO is gaining traction due to a positive perception of its prebiotic properties that help maintain a healthy immune system in infants. In addition, manufacturers are focusing on increasing their production capacities in order to enhance production of HMOs such as 2’-FL (2-fucosyllactose) that can be potentially used as an ingredient in functional food and beverages. zuChem Inc., Glycosyn LLC, Elicityl SA, Jennewein Biotechnologie GmbH, Glycom A/S, Dextra Laboratories Limited, Carbosynth Limited, Inbiose NV, ProZyme, Inc. are the leading companies operating in the global human milk oligosaccharides market.
Key Excerpts of the Report Include:
For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-4252
Expert analysis, actionable insights, and strategic recommendations – the food & beverage team at Future Market Insights helps clients from across the globe with their unique business intelligence needs. With a repertoire of over 1,000 reports and 1 million+ data points, the team has analysed the food & beverage industry lucidly in 50+ countries for over a decade. The team provides end-to-end research and consulting services; reach out to explore how we can help.
Explore FMI’s Extensive Coverage on the Food & Beverage Domain
Food Certification Market – 2021 Analysis and Review: Food certification Market by Application – Meat, Poultry, Seafood, Dairy, Infant Food, Beverages, and Bakery & Confectionary for 2021 – 2031
Animal Feed Additives Market – 2021 Analysis and Review: Animal Feed Additives Market by Source Type – Plant, Animal, and Micro-Organisms for 2021-2031
Infant Formula Market – 2021 Analysis and Review: Infant Formula by Product –Starting Milk Formula, Follow-on Milk Formula, Toddlers Milk Formula, and Special Milk Formula for 2021 – 2031
CAGR stands for Compound Annual Growth Rate, which measures the mean annual growth rate of an investment over a specified time period, assuming the investment grows at a steady rate.
Regulatory approvals ensure that products containing HMOs meet safety and quality standards, which is crucial for their use in infant formulas and other food products.
Explore more articles in the Research Reports category
